Evidence map›Paper›PMID 31645654›Full record

ReviewJournal of human genetics2020

Mutations in MTHFR and POLG impaired activity of the mitochondrial respiratory chain in 46-year-old twins with spastic paraparesis.

Arnaud Wiedemann, Céline Chery, David Coelho, Justine Flayac, Naïg Gueguen, Valérie Desquiret-Dumas, François Feillet, Christian Lavigne, Jean-Philippe Neau, Brian Fowler and 4 more

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Novel MTHFR variants manifesting with hereditary spastic paraplegia and recurrent pulmonary embolism: a case report and literature review of adult-onset severe MTHFR deficiency.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Arnaud WiedemannINSERM UMR_S 1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure and Reference Centre for Inherited Metabolic Diseases (ORPHA67872), University Hospital of Nancy and Faculty of Medicine of Nancy, University of Lorraine, Nancy, France.
Céline CheryINSERM UMR_S 1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure and Reference Centre for Inherited Metabolic Diseases (ORPHA67872), University Hospital of Nancy and Faculty of Medicine of Nancy, University of Lorraine, Nancy, France.
David CoelhoINSERM UMR_S 1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure and Reference Centre for Inherited Metabolic Diseases (ORPHA67872), University Hospital of Nancy and Faculty of Medicine of Nancy, University of Lorraine, Nancy, France.ORCID http://orcid.org/0000-0001-7010-5789
Justine FlayacINSERM UMR_S 1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure and Reference Centre for Inherited Metabolic Diseases (ORPHA67872), University Hospital of Nancy and Faculty of Medicine of Nancy, University of Lorraine, Nancy, France.
Naïg GueguenDepartment of Biochemistry and Genetics, UMR CNRS 6214-INSERM 1083, University Hospital Centre, Angers, France.
Valérie Desquiret-DumasDepartment of Biochemistry and Genetics, UMR CNRS 6214-INSERM 1083, University Hospital Centre, Angers, France.
François FeilletINSERM UMR_S 1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure and Reference Centre for Inherited Metabolic Diseases (ORPHA67872), University Hospital of Nancy and Faculty of Medicine of Nancy, University of Lorraine, Nancy, France.
Christian LavigneDepartment of Internal Medicine and Vascular Medicine, University Hospital Centre, Angers, France.
Jean-Philippe NeauDepartment of Neurology, University Hospital Centre, Poitiers, France.
Brian FowlerDivision of Metabolism and Children's Research Centre, University Children's Hospital, Zürich, Switzerland.
Matthias R BaumgartnerDivision of Metabolism and Children's Research Centre, University Children's Hospital, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-9270-0826
Pascal ReynierDepartment of Biochemistry and Genetics, UMR CNRS 6214-INSERM 1083, University Hospital Centre, Angers, France.
Jean-Louis GuéantINSERM UMR_S 1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure and Reference Centre for Inherited Metabolic Diseases (ORPHA67872), University Hospital of Nancy and Faculty of Medicine of Nancy, University of Lorraine, Nancy, France. jean-louis.gueant@univ-lorraine.fr.
Abderrahim OussalahINSERM UMR_S 1256, NGERE-Nutrition, Genetics, and Environmental Risk Exposure and Reference Centre for Inherited Metabolic Diseases (ORPHA67872), University Hospital of Nancy and Faculty of Medicine of Nancy, University of Lorraine, Nancy, France. abderrahim.oussalah@univ-lorraine.fr.ORCID http://orcid.org/0000-0002-9731-4529
Inserm · FRCentre National de la Recherche Scientifique · FRUniversity Children's Hospital Zurich · CHCentre Hospitalier Universitaire de Poitiers · FRUniversité d'Angers · FR

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) SNSF 31003A_138521
6 · The paper itself

Abstract

Hereditary spastic paraplegias (HSPs) are characterized by lower extremity spasticity and weakness. HSP is often caused by mutations in SPG genes, but it may also be produced by inborn errors of metabolism. We performed next-generation sequencing of 4813 genes in one adult twin pair with HSP and severe muscular weakness occurring at the same age. We found two pathogenic compound heterozygous variants in MTHFR, including a variant not referenced in international databases, c.197C>T (p.Pro66Leu) and a known variant, c.470G>A (p.Arg157Gln), and two heterozygous pathogenic variants in POLG, c.1760C>T (p.Pro587Leu) and c.752C>T (p.Thr251Ile). MTHFR and POLG mutations were consistent with the severe muscle weakness and the metabolic changes, including hyperhomocysteinemia and decreased activity of both N(5,10)methylenetetrahydrofolate reductase (MTHFR) and complexes I and II of the mitochondrial respiratory chain. These data suggest the potential role of MTHFR and POLG mutations through consequences on mitochondrial dysfunction in the occurrence of spastic paraparesis phenotype with combined metabolic, muscular, and neurological components.

Indexed as

DNA Polymerase gammaFemaleHeterozygoteHigh-Throughput Nucleotide SequencingHumansMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedMitochondrial DiseasesMutationParaparesis, SpasticSequence Analysis, DNASpastic Paraplegia, HereditaryTwins, MonozygoticDNA Polymerase gammaMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanPOLG protein, human

Identifiers

PMID31645654
OpenAlexW2981940435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.